KYMR:NASDAQ
Kymera Therapeutics Inc
$114.63
arrow_downward
-0.29%(-0.33) 1D
$114.63
0.00% (0.00)
bedtimeAfter hours
Closed: Sep 14, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for KYMR...
Open
$116.01
High
$117.85
Low
$114.32
Mkt. cap
9.53B
Avg. vol.
672.23K
Volume
499.01K
52-wk high
$130.05
52-wk low
$46.25
EPS
-$3.24
Beta
1.96
Shares outstanding
83.15M
No. of employees
273
Open
$116.01
High
$117.85
Low
$114.32
Mkt. cap
9.53B
Avg. vol.
672.23K
Volume
499.01K
52-wk high
$130.05
52-wk low
$46.25
EPS
-$3.24
Beta
1.96
Shares outstanding
83.15M
No. of employees
273
News stories
From web sources and news partners
Investing.com
·
4 hours ago
Kymera Therapeutics at H.C. Wainwright: oral drug push gains pace
GuruFocus
·
7 hours ago
KYMR Maintained by B of A Securities -- Price Target Raised to $144
Investing.com
·
15 hours ago
BofA raises Kymera Therapeutics price target on trial progress
About Kymera Therapeutics Inc
CEO-
Employees273
Founded2015
HeadquartersWatertown, Massachusetts, United States
SectorBiotechnology
Websitekymeratx.com